Primary central nervous system lymphoma: A real-world comparison of therapy access and outcomes by hospital setting

Akshat M. Patel, Omer Ali, Radhika Kainthla, Syed M. Rizvi, Farrukh T. Awan, Toral Patel, Edward Pan, Elizabeth Maher, Neil B. Desai, Robert Timmerman, Kiran A. Kumar, Praveen Ramakrishnan Geethakumari

Research output: Contribution to journalReview articlepeer-review

5 Scopus citations

Abstract

Background: This study analyzes sociodemographic barriers for primary CNS lymphoma (PCNSL) treatment and outcomes at a public safety-net hospital versus a private tertiary academic institution. We hypothesized that these barriers would lead to access disparities and poorer outcomes in the safety-net population. Methods: We reviewed records of PCNSL patients from 2007-2020 (n = 95) at a public safety-net hospital (n = 33) and a private academic center (n = 62) staffed by the same university. Demographics, treatment patterns, and outcomes were analyzed. Results: Patients at the safety-net hospital were significantly younger, more commonly Black or Hispanic, and had a higher prevalence of HIV/AIDS. They were significantly less likely to receive induction chemotherapy (67% vs 86%, P =. 003) or consolidation autologous stem cell transplantation (0% vs. 47%, P =. 001), but received more whole-brain radiation therapy (35% vs 16%, P =. 001). Younger age and receiving any consolidation therapy were associated with improved progression-free (PFS, P =. 001) and overall survival (OS, P =. 001). Hospital location had no statistical impact on PFS (P =. 725) or OS (P =. 226) on an age-adjusted analysis. Conclusions: Our study shows significant differences in treatment patterns for PCNSL between a public safety-net hospital and an academic cancer center. A significant survival difference was not demonstrated, which is likely multifactorial, but likely was positively impacted by the shared multidisciplinary care delivery between the institutions. As personalized therapies for PCNSL are being developed, equitable access including clinical trials should be advocated for resource-limited settings.

Original languageEnglish (US)
Pages (from-to)183-192
Number of pages10
JournalNeuro-Oncology Practice
Volume9
Issue number3
DOIs
StatePublished - May 1 2022
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2022 The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology and the European Association of Neuro-Oncology. All rights reserved.

Keywords

  • health services accessibility
  • healthcare disparities
  • outcomes
  • practice patterns
  • primary CNS lymphoma (PCNSL)

Fingerprint

Dive into the research topics of 'Primary central nervous system lymphoma: A real-world comparison of therapy access and outcomes by hospital setting'. Together they form a unique fingerprint.

Cite this